PK Assays for Antibody–Drug Conjugates: Case Study with Ado-Trastuzumab Emtansine

Abstract

The bioanalytical strategy was successfully applied to the drug development of T-DM1 and ensured that key analytes were accurately measured in support of nonclinical and clinical development.